Ningbo Menovo Stock Hits Day High with 10.01% Surge

Ningbo Menovo Pharmaceutical Co., Ltd. has experienced a significant surge in its stock price, gaining 10.01% on July 10, 2026. The stock reached an intraday high of CNY 30.88, showcasing its strong performance against the backdrop of a declining China Shanghai Composite, which fell by 1.0% on the same day. Over the past week, Ningbo Menovo has outperformed the market with an 11.39% increase, and its one-month performance stands at 12.29%. Impressively, the stock has delivered a remarkable 78.94% return over the past year, significantly surpassing the China Shanghai Composite's 13.86% gain. Year-to-date, the stock has soared by 124.7%, reflecting its robust market position. Despite these positive trends, the company faces challenges, including a high debt-to-equity ratio and modest long-term growth in net sales and operating profit. However, recent financial metrics indicate improvements, such as a notable increase in net sales and a favorable debtors turnover ratio. With a market capitalization of CNY 8,201 million, Ningbo Menovo continues to navigate the competitive pharmaceuticals and biotechnology landscape.